
Patients with COVID-19 and neurological manifestations show undetectable SARS-CoV-2 RNA levels in the cerebrospinal fluid
2020; Elsevier BV; Volume: 96; Linguagem: Inglês
10.1016/j.ijid.2020.05.123
ISSN1878-3511
AutoresOtávio de Melo Espíndola, Marilda Mendonça Siqueira, Cristiane Soares, Marco Antônio Lima, Ana Claúdia Celestino Bezerra Leite, Abelardo Araújo, Carlos Otávio Brandão, Marcus Tulius T. Silva,
Tópico(s)Multiple Sclerosis Research Studies
ResumoWe report that patients with COVID-19 displaying distinct neurological disorders have undetectable or extremely low levels of SARS-CoV-2 RNA in the cerebrospinal fluid, indicating that viral clearance precede the neurological involvement. This finding points to the need for the development of more sensitive molecular tests and the investigation of other neurotropic pathogens to exclude concurrent neuroinfection.
Referência(s)